Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. toxicology
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Toxicology Articles & Analysis: Older

74 news found

Ace Therapeutics Releases BBBporter™ Technology Platform to Overcome the Challenges of Brain Drug Delivery

Ace Therapeutics Releases BBBporter™ Technology Platform to Overcome the Challenges of Brain Drug Delivery

Its expertise spans various preclinical services, including efficacy testing, pharmacokinetics, toxicology, and biomarker development, to support clients in their research and development efforts. ...

ByAce Therapeutics


Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development

Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development

Preclinical development Creative Diagnostics provides in vitro biology, in vivo pharmacodynamics, PK/PD, toxicology and formulation development services that enable clients to make decisions about drug candidates, advance the development process and reduce future time and costs. ...

ByCreative Diagnostics


CD Formulation Announces Festive Discounts: 5%-15% Off on All Products and Services

CD Formulation Announces Festive Discounts: 5%-15% Off on All Products and Services

They include efficacy tests, microbial contamination reports and full-service toxicological risk assessment. CD Formulation aids brands in protecting their reputation and fortifying consumer trust. ...

ByCD Formulation


Precision Aerosol Therapy Through AI and flexiVent-Controlled Delivery

Precision Aerosol Therapy Through AI and flexiVent-Controlled Delivery

Yang, L., et al (2024) introduces LungVis 1.0, an AI-driven imaging platform integrating light sheet fluorescence microscopy (LSFM) and deep learning for mapping nanoparticle (NP) deposition across murine lungs. The research highlights the advantages of aerosol-based delivery methods over traditional liquid-based approaches, emphasizing the uniformity of NP deposition in distal alveolar ...

BySCIREQ - an emka TECHNOLOGIES Company


Creative Diagnostics Introduces Patulin Test Reagents for Food Safety Applications

Creative Diagnostics Introduces Patulin Test Reagents for Food Safety Applications

Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for food, feed, environmental and toxicological sample analysis, announces the availability of its high-quality Patulin Test Reagents. ...

ByCreative Diagnostics


Amerigo Scientific Enhances Cell Culture Results by Introducing 3D Cell Culture Systems

Amerigo Scientific Enhances Cell Culture Results by Introducing 3D Cell Culture Systems

By providing scientists with tools that better mimic the complex biological processes that occur in vivo, these products enable more accurate and reliable results in drug discovery, toxicology studies, and regenerative medicine research. “We are excited to bring these cutting-edge 3D cell culture systems to our customers,” said the business development manager at ...

ByAmerigo Scientific


CD Formulation Offers Robust Expertise in Pharmacology to Aid Veterinary Drug Development

CD Formulation Offers Robust Expertise in Pharmacology to Aid Veterinary Drug Development

Focus on Pharmacokinetics and Toxicology Understanding a drug's absorption, distribution, metabolism, and excretion (ADME) in animal bodies is crucial for determining appropriate dosages and minimizing adverse effects. ...

ByCD Formulation


Alfa Chemistry Leads the Way in Tailored Preclinical Drug Research Solutions

Alfa Chemistry Leads the Way in Tailored Preclinical Drug Research Solutions

Comprehensive Project Services Furthermore, Alfa Chemistry provides one-stop biopharmaceutical R&D outsourcing services that encompass the entirety of drug research, encompassing different disciplines such as hemistry, biology, pharmacodynamic evaluation, pharmacokinetic evaluation, and toxicological evaluation. These services include ADC preclinical development, biological ...

ByAlfa Chemistry


Alfa Chemistry Unveils Its Latest Offering of Bioactive Molecules for Scientific Breakthroughs

Alfa Chemistry Unveils Its Latest Offering of Bioactive Molecules for Scientific Breakthroughs

In most cases, bioactive molecules exhibit therapeutic, preventing, toxicological and immunostimulating activities. “Bioactive molecules can regulate, modify or modulate a variety of cellular functions including enzymatic activities, signal transduction, gene regulation, and protein function. ...

ByAlfa Chemistry


Araris Biotech appoints Bernd Schlereth as Chief Development Officer

Araris Biotech appoints Bernd Schlereth as Chief Development Officer

Schlereth worked for six years as Senior Director Pharmacology and Toxicology at Micromet, and he started in 2000 his career in industry at Bavarian Nordic. In these positions he was responsible for the Discovery, Pharmacology, Toxicology and DMPK (Drug Metabolism & Pharmacokinetics) activities in close collaboration with CMC (chemistry, manufacturing, ...

ByAraris Biotech AG


Eagle Pharmaceuticals Provides Business Update and Guidance for 2023

Eagle Pharmaceuticals Provides Business Update and Guidance for 2023

Commercial and Pipeline Update Product portfolio Acute Care Hospital: RYANODEX®, vasopressin, Barhemsys®, Byfavo® Oncology: BENDEKA, BELRAPZO, PEMFEXY11, TREAKISYM Japan12 75-person commercial team covers all products excluding BENDEKA and TREAKISYM Company projects growth in earnings while still supporting R&D Cash flow from legacy products expected to continue to ...

ByEagle Pharmaceuticals, Inc.


Antengene Enters into a Global Clinical Collaboration with MSD to Evaluate ATG-037 (CD73 Inhibitor) in Combination with KEYTRUDA (pembrolizumab)

Antengene Enters into a Global Clinical Collaboration with MSD to Evaluate ATG-037 (CD73 Inhibitor) in Combination with KEYTRUDA (pembrolizumab)

In preclinical studies, the compound has demonstrated the ability to overcome the “hook effect” that has been observed in some anti-CD73 antibodies. In addition, GLP toxicology studies indicate the compound potentially has a wide therapeutic window. ...

ByAntengene Corporation Limited


Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination

Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination

In addition to samuraciclib, Carrick is also developing a novel CDK12/13 inhibitor / Cyclin-K glue-degrader which has advanced into IND enabling toxicology ...

ByThe Menarini Group


Full-Scale PROTAC In Vivo Evaluation Services to Facilitate PROTAC Drug R&D

Full-Scale PROTAC In Vivo Evaluation Services to Facilitate PROTAC Drug R&D

Its PROTAC in vivo evaluation services encompass general studies of toxicology and in vivo pharmacokinetics, tests of allergy and in vitro hemolysis, as well as immunotoxicology analysis. ...

ByBOC Sciences


Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73 Inhibitor) for the Treatment of Locally Advanced or Metastatic Solid Tumors in China

Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73 Inhibitor) for the Treatment of Locally Advanced or Metastatic Solid Tumors in China

In preclinical studies, the compound has demonstrated the ability to overcome the “hook effect” that has been observed in some anti-CD73 antibodies. In addition, GLP toxicology studies indicate the compound potentially has a wide therapeutic window. ...

ByAntengene Corporation Limited


Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes

Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes

In silico modelling for CYP in preclinical species can also reduce animal testing in toxicology studies, making trials quicker, less expensive, and more ethical. ...

ByOptibrium Ltd.


PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022

PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022

These findings suggest that PMC-309 can offer a new treatment strategy in immuno-oncology area as it can be used in combination with other drugs to improve their low-response rates. The GLP-Toxicology studies are already completed, and no serious safety issues were observed. ...

ByPharmAbcine Inc.


Enalare Therapeutics Receives an Additional Award Worth Up to $50 Million From BARDA, Expanding Its Partnership in Development of ENA-001

Enalare Therapeutics Receives an Additional Award Worth Up to $50 Million From BARDA, Expanding Its Partnership in Development of ENA-001

The Funding Supports Development of an Intramuscular ENA-001 From Pre-Clinical Toxicology Through Filing for Approval in the United States Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life-threatening critical care diseases and community medical threats, announced today that it has received a ...

ByEnalare Therapeutics Inc.


Orphan Drug Designations by the U.S. FDA are meant to support the development of drug candidates that could potentially bring substantial therapeutic benefits

Orphan Drug Designations by the U.S. FDA are meant to support the development of drug candidates that could potentially bring substantial therapeutic benefits

Furthermore, ATG-101 has also shown an excellent safety profile in Good Laboratory Practice (GLP) toxicology studies. ATG-101 is the first PD-L1/4-1BB bispecific antibody entering clinical development in Australia and is currently being evaluated in clinical studies in Australia, China, and the U.S. ...

ByAntengene Corporation Limited


CD Formulation Offers Insights, Strategies, and Practical Suggestions on Pre-formulation Studies for Pharmaceuticals

CD Formulation Offers Insights, Strategies, and Practical Suggestions on Pre-formulation Studies for Pharmaceuticals

A deep and thorough understanding of drug products is required, including different parameters such as the toxicology, pharmacokinetics, and physicochemical properties of drug chemicals,” said the Marketing Chief of CD Formulation. ...

ByCD Formulation

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT